Dataset
patent_embedding
Qwen3-4B Patent Embeddings (专利特征向量数据集) 📌 简介 (Introduction) 本数据集包含了海量专利文本的特征向量（Embeddings）。所有特征向量均使用强大的 Qwen3-embedding-4B 模型提取。 数据领域: 专利 (Patents) 特征提取模型: Qwen3-embedding-4B 数据格式: .mmap (Memory-mapped file, numpy-compatible) + .tsv 数据精度: float16 📂 数据结构 (Data Structure) 由于数据量庞大，在生成时使用了 4 张 GPU 进行分布式计算，因此数据被划分为 4 个分片（Shards）：shard_0 到 shard_3。 每个 Shard 目录下包含以下核心文件： embeddings.float16.mmap: 核心的特征向量矩阵
Data preview
Dataset card
patent_embedding is listed on Hugging Face by TMSDMAP.
The listing has drawn 64 downloads and 0 likes on Hugging Face.
The data
The source tags it with embeddings, patents and qwen3.
Documentation & references 1
Related datasets
Browse moreParsed eligibility criteria from 13,229 ClinicalTrials.gov studies representing the candidate pool gathered by two first-stage retrievers during TREC Clinical Trials 2021–2023, formatted as typed entity-relation graphs for reranking models.
The clinical-trials-patient-graphs dataset is a small tabular collection of patient-level clinical records distributed in Parquet format by the 2001jdev publisher. It organizes entities and relations extracted from trial data into structured rows spanning 2021 through 2023.
This dataset is a parsed snapshot of ClinicalTrials.gov records, distributed in Parquet format on the Hugging Face Hub under an unspecified license. It contains roughly 52,000 trial entries drawn from public registry filings.
clinical-trials-trec-qrels is a tabular relevance-judgment file distributed by the 2001jdev user on the Hugging Face Hub. It maps clinical-trial topic identifiers to NCT registry IDs with graded relevance scores.
The clinical-trials-trec-topics dataset is a small tabular collection of clinical-trial topic records distributed in Parquet format on the Hugging Face Hub. It appears to be derived from TREC clinical-trial retrieval topics, with rows partitioned by year.
SEC EDGAR 10-K & 10-Q financial statements for 2,600+ NASDAQ companies.
Discussion
Questions or observations about this dataset? Join the conversation on X.
No comments yet. Start the conversation on X.